Clinical trial for Glaucoma
Official title Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)
ClinicalTrials.gov ID: NCT04339907
What this study is testing
- What it's testing
- This study is looking at whether chemicals in eye fluid and tears can show early signs of glaucoma after a corneal transplant.
- Who it's for
- You may be able to join if you have a Boston keratoprosthesis type 1 and have had a corneal transplant.
- What's involved
- You would give small samples of eye fluid and tears during clinic visits. The team will analyze these samples for inflammation signs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18 years old or older
- Informed consent
- Ability to be followed for the duration of the study
- Group 1 : have no glaucoma and no systemic diseases
- Group 2 : need to have glaucoma filtration surgery without prior corneal transplantation
You likely can't join if
- Aged less than 18
- Inability to give informed consent
- Presence of ocular diseases other than those studied herein
See the full eligibility criteria
- Aged 18 years old or older
- Informed consent
- Ability to be followed for the duration of the study
- Group 1 : have no glaucoma and no systemic diseases
- Group 2 : need to have glaucoma filtration surgery without prior corneal transplantation
- Group 3 : need to have corneal transplantation (penetrating keratoplasty or Boston keratoprosthesis), with or without glaucoma
- Group 4 : need to have intraocular surgery after prior corneal transplantation (penetrating keratoplasty or Boston keratoprosthesis)
- Group 5 : need to have glaucoma filtration surgery with prior corneal transplantation (penetrating keratoplasty or Boston keratoprosthesis)
- Aged less than 18
- Inability to give informed consent
- Presence of ocular diseases other than those studied herein
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.